{"nct_id":"NCT06419205","title":"A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G","status":"WITHDRAWN","status_verified_date":"2024-12","start_date":"2024-06-27","start_date_type":"ACTUAL","primary_completion_date":"2026-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["QTTB"]}